|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 3 February 2021, 8:15. The announcement is not marked as price sensitive, and is 11 page(s) in length and 5.18MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.031% short sold according to ASIC data. It was ranked the 100th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Change in substantial holding | 3 February 2021, 8:15 |
| Quarterly Cashflow and Activities Report | 29 January 2021, 10:03 |
| Appendix 2A | 27 January 2021, 14:40 |
| Change in substantial holding | 18 January 2021, 8:20 |
You must be logged in to post a reply.
Starpharma Holdings 